News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Michael Klichinsky: Carisma Therapeutics received FDA Fast Track Designation for CT-0525
A collage of Michael Klichinsk and Carisma Therapeutics
Jun 27, 2024, 12:32

Michael Klichinsky: Carisma Therapeutics received FDA Fast Track Designation for CT-0525

Michael Klichinsky, Co-Founder and Chief Scientific Officer at Carisma Therapeutics, shared on LinkedIn:

“We are excited to share that Carisma Therapeutics received FDA Fast Track Designation for CT-0525 for the treatment of advanced HER2-overexpressing solid tumors.

More information here.”

Source: Michael Klichinsky/LinkedIn

cancer Carisma Therapeutics CT-0525 FDA HER2 Michael Klichinsky OncoDaily Oncology solid tumors
Special Coverage
Voices
Aug 10, 2025, 15:36
Wafaa M Rashed: Africa for Africans - Shaping the Future of Genomics Policy
Career
Aug 10, 2025, 15:36
Bogda Koczwara: Join the Team of Australian Research Centre for Cancer Survivorship
Voices
Aug 10, 2025, 15:26
Sendurai Mani: Joining the Partnership to Reduce Cancer in Rhode Island Membership Meeting
Career
Aug 10, 2025, 15:00
Santosh Rao Joined to the HemOnc Department at Cleveland Clinic Akron General as the Medical Director
Science
Aug 10, 2025, 14:54
Monika J Dziuba: The Role of Organoids in Precision Medicine
Voices
Aug 10, 2025, 14:50
The Future of Pharmaceutical Infrastructure and Equitable Access to Medicines - Hikma Pharmaceuticals
Voices
Aug 10, 2025, 14:31
Anju Aledia: Celebrating Strength, Unity, and Hope Among Children Fighting Cancer
Voices
Aug 10, 2025, 14:19
Harish Nagaraj: Advancing Neuroendocrine Tumor Care in East and Sub-Saharan Africa
Opinion
Aug 10, 2025, 13:44
Olivier Elemento: Accelerating Innovation with Safe and Effective Guardrails
Voices
Aug 10, 2025, 13:01
Olubukola Ayodele: Breast Cancer Subtypes and What They Mean for Patients and Treatment
Voices
Aug 10, 2025, 12:49
Krishna Soujanya Gunturu: The Hartford HealthCare Cancer Institute Has Launched First-in-Human Phase 1A Clinical Trial
Blog
Aug 10, 2025, 12:46
Ashwin Mallya: Bladder Cancer Care is No Longer a Solo Act